RUDNICK STANFORD enters SYNEOS HEALTH, INC. with 31.52K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 4/10/2023ACC: 0001209191-23-023918
Officer· See remarks
Since Mar 2023
31.52K
Baseline shares
100% direct
31.52K
Direct ownership
1 position
703.00
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Class A Common Stock
DirectShares owned31.52K
Total
31.52K direct31.52K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 31.52K | Direct |
| Total | 31.52K | 31.52K direct |
Derivative Holdings2
Stock Option (Right to Buy Class A Common Stock)
DirectUnderlying security
Class A Common Stock
Underlying shares
537.00
Shares owned
N/A
Exercise price
42.88
Expiration
—
Exercise window
—
Stock Option (Right to Buy Class A Common Stock)
DirectUnderlying security
Class A Common Stock
Underlying shares
166.00
Shares owned
N/A
Exercise price
43.16
Expiration
—
Exercise window
—
Total
Underlying
703.00
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock) Direct | Class A Common Stock | 42.88 | — | — | 537.00 | N/A |
| Stock Option (Right to Buy Class A Common Stock) Direct | Class A Common Stock | 43.16 | — | — | 166.00 | N/A |
| Total | 703.00 | 0.00 | ||||